Welcome to Macroaxis
Sign in to go to your portfolios
Don't have an account? Create It
  Macroaxis: Personalized Investing   The proven technology to invest wisely
Macroaxis Country Selector USA  Change      Macroaxis User Registration Register    Macroaxis User Login Sign In
   
  
 
US Market Closed: May 26, 06:55 AM 2012  
PTTCX PTRAX PTTAX PTRRX PTTPX PTTBX 
 
 
  NYSE  7,534  18.032  Index Moved Down 



Processing
Collecting data for GNBT and HSP ...

Asset Comparison and Correlation

    
       
Investment horizon: 
30 Days (Login to change)
       
 
    
 Generex Biotechnology Corp.  and   Hospira Inc.
Check Correlation Matrix  
Daily Returns (%)
GNBT  HSP  
Timeline
Given investment horizon of 30 days, Generex Biotechnology Corporation is expected to generate 3.39 times more return on investment than Hospira. However, Generex is 3.39 times more volatile than Hospira Inc.. It trades about -0.07 of its potential returns per unit of risk. Hospira Inc. is currently generating about -0.26 per unit of risk. If you would invest 10.00 in Generex Biotechnology Corporation on April 26, 2012 and sell it today you would earn a total of 0.00 from holding Generex Biotechnology Corporation or generate 0.0% return on investment over 30 days.

Diversification

Good diversification
Overlapping area represents amount of risk that can be diversified away by holding Generex Biotechnology Corp. and Hospira Inc. in the same portfolio (assuming nothing else is changed)

Correlation Coefficient

-0.18
 Parameters
Time Period1 Month [change]
DirectionNegative GNBT Moved Down vs HSP
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns
    
Follow Correlation between GNBT and HSP with your standard RSS feed, custom widget, or your favorite social app
Add To Reader
 
Add Correlation between GNBT and HSP to your reader
 
Get social with Correlation between GNBT and HSP
 Share Correlation between GNBT and HSP 
Share Share Correlation between GNBT and HSP
    
    
 
       
Predicted Return Density
Expected Daily Returns   
GNBT  HSP  

Generex Biotechnology Corporation

 
    
    
Generex
Performance
0
Out Of
100
Over 30
Days
Over the last 30 days Generex Biotechnology Corporation has generated negative risk-adjusted returns adding no value to investors with long positions.
    
    
PIMCO Total Return Admin vs. Generex Biotechnology Corporation
PIMCO Total Return D vs. Generex Biotechnology Corporation
PIMCO Total Return A vs. Generex Biotechnology Corporation
PIMCO Total Return B vs. Generex Biotechnology Corporation
PIMCO Total Return Instl vs. Generex Biotechnology Corporation
PIMCO Total Return C vs. Generex Biotechnology Corporation
  

Hospira Inc.

 
    
    
Hospira
Performance
0
Out Of
100
Over 30
Days
Over the last 30 days Hospira Inc. has generated negative risk-adjusted returns adding no value to investors with long positions.
    
    
Valeant Pharmaceuticals International Inc. vs. Hospira Inc.
Elan Corporation plc vs. Hospira Inc.
Alkermes Inc. vs. Hospira Inc.
PetMed Express Inc. vs. Hospira Inc.
Acura Pharmaceuticals Inc. vs. Hospira Inc.
Flamel Technologies SA vs. Hospira Inc.
       


 

 
Analytics
Investor Landscape
Efficient Frontier
Market Correlation
Risk and Return Analysis
Financial Content
Portfolio Projections
Portfolio Backtesting
Tools
FAQs
Retirement Optimizer
RSS and Mobile Access
Company Directory
Advisor Directory
Insider Directory
Wealth Management
About Us
About Macroaxis
Contact Us
Terms Of Use
Privacy Policy
Custom Reporting
Product Tour
More ROI Custom Reporting